Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Eye-disease-focused Acelyrin will be absorbed into immune-mediated disease specialist Alumis as part of an all-stock merger.

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

It’s also important to note that psoriasis is largely described as a physical condition with visible symptoms that you’re able to see with your eye. But when it comes to pain, research shows ...

While you're getting treated for psoriasis, make sure you find a way to manage the stress and emotions that may tag along. Reach out to family, friends, and support groups to get the backing you need.

SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long term, according to a study from the UK and Ireland. Patients with ...

The psoriasis treatment that works for you initially may not continue working long term. Some benefits of trying a new treatment can include improved skin clearance, fewer side effects ...

Taking steps to protect the eye and avoiding certain activities is important during recovery from cataract surgery. These include avoiding bending over and vigorous sneezing or coughing.

A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.

Photographs taken of the retina at the back of the eye can give an indication of brain health, and by using AI software to analyse the information, scientists may be able to spot signs of disease ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for "leaky gut," according to new research at Uppsala University.

Psoriasis is a hereditary, chronic skin condition that can also result in inflammation of the joints. In Sweden, almost 300,000 people live with some form of the condition.